MedTrace Logo

Sleep Disordered Breathing and Chronic Pain

NCT01457014 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2016-02-19

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate positive pressure in patients with chronic pain taking opioid medications who have sleep disordered breathing.

Conditions

  • Sleep Apnea Syndromes

Interventions

DEVICE

servo ventilation auto

Expiratory pressure automatically adjusted to stabilize the upper airway. Inspiratory pressure automatically adjusted to deliver consistent peak flow.

DEVICE

Continuous positive airway pressure

continuous positive airway pressure

DEVICE

servo ventilation manual

servo ventilation titrated in manual mode

Sponsors & Collaborators

  • Philips Respironics

    lead INDUSTRY

Principal Investigators

  • Paul Wylie, MD · Arkansas Center of Sleep Medicine

  • Vernon Pegram, PhD · Sleep D/O Center of Alabama

  • Mark Muehlbach, PhD · Clayton Sleep Institute

  • Russell Rosenberg, MD · NeuroTrials Research, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2013-04-30
Completion
2013-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01457014 on ClinicalTrials.gov